Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety of GANFORT® (Bimatoprost 0.03% Plus Timolol 0.5%) Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension

NCT02571712 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02571712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02571712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety of GANFORT® (Bimatoprost 0.03% Plus Timolol 0.5%) Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
November 10, 2015
Completion date
June 21, 2018
Enrollment
750 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, ocular hypertension